An international team led by investigators at Pfizer Oncology, BGI-Shenzhen, the University of Copenhagen, and Eli Lilly and Company used whole-genome sequencing to track down recurrent genetic glitches in the liver cancer hepatocellular carcinoma — particularly forms of the disease involving hepatitis B virus infection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PLOS

This Week in Cell

This Week in Science

This Week in PNAS

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.